CD4+CXCR3+Th1 cells that migrate to the pancreas during the initial phase of AIP are unique in that they are potent producers of C-C chemokine ligand 25 (CCL25) and attract C-C chemokine receptor 9 (CCR9)-expressing cells. Here, CCL25 is linked to autoimmune pancreatitis.